TITLE

Research Capsules

PUB. DATE
June 2007
SOURCE
Pharmaceutical Representative;Jun2007, Vol. 37 Issue 6, p13
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports developments on studies concerning health products. GlaxoSmithKline's investigational extended-release formulation of ropinirole, Requip XL, may decrease when symptoms return in patients with advanced Parkinson's disease. Phase III study shows that adding Tarceva to chemotherapy with Gemzar may improve survival in patients with advanced pancreatic cancer.
ACCESSION #
25360919

 

Related Articles

  • UK audit highlights need for caution with chemotherapy in very sick patients. Mayor, Susan // BMJ: British Medical Journal (International Edition);11/15/2008, Vol. 337 Issue 7679, p1130 

    The article reports on the results of a study which was conducted by the UK National Confidential Enquiry into Patient Outcome and Death and which were published in November of 2008. Researchers reviewed the quality of care that was provided to more than 600 patients who received cancer...

  • Retrospective evaluation of weekly paclitaxel hypersensitivity reactions reported utilizing an electronic medical record system at a tertiary cancer center. Lal, Lincy S.; Gerber, Donna L.; Lau, Jason; Dana, William // Supportive Care in Cancer;Oct2009, Vol. 17 Issue 10, p1311 

    Objectives This is a retrospective observational study evaluating hypersensitivity reactions captured by an electronic medical record (EMR) system for weekly paclitaxel infusions. Materials and methods The study evaluates the demographics, co-morbidities, premedications, chemotherapy agents, and...

  • Veralipride: withdrawal following review of risk/benefit.  // WHO Drug Information;2005, Vol. 19 Issue 4, p302 

    The article focuses on the announcement of marketing withdrawal of the menopausal treatment veralipride, an antidopamine agent, by the Spanish Agency for Medicines and Health Products. This veralipride has been marketed since 1983 for the treatment of not flushes and other menopausal symptoms....

  • THE LATEST WORD ON THE NEWEST RESEARCH.  // Alive;Oct2012, Issue 360, p178 

    This section presents an update on health and medical research. A study found that people with Parkinson's disease who took 100 to 200 milligram of caffeine for six weeks reported improvement in severity of Parkinson's symptoms, better movement speed, and reduced stiffness. A study found that...

  • Noteworthy.  // Pharmaceutical Representative;Jun2007, Vol. 37 Issue 6, p17 

    The article reports developments related to public health in the U.S. Researchers at the University of Southern California found that people's risk of being diagnosed with late-stage cancer is linked to where they are living. Researchers at Duke University Medical Center found that smoking and...

  • Effects of stimulus-response compatibility in Parkinson’s disease: a psychophysiological analysis. Falkenstein, M.; Willemssen, R.; Hohnsbein, J.; Hielscher, H. // Journal of Neural Transmission;Oct2006, Vol. 113 Issue 10, p1449 

    The present study investigated the mechanisms underlying stimulus-response compatibility effects in Parkinson’s disease patients and matched controls. Since basal ganglia are involved in the selection and inhibition of competing responses we examined whether basal ganglia dysfunction in...

  • The impact of radiotherapy late effects on quality of life in gynaecological cancer patients. Barker, C. L.; Routledge, J. A.; Farnell, D. J. J.; Swindell, R.; Davidson, S. E. // British Journal of Cancer;5/1/2009, Vol. 100 Issue 10, p1558 

    The aims of this study were to assess changes in quality of life (QoL) scores in relation to radical radiotherapy for gynaecological cancer (before and after treatment up to 3 years), and to identify the effect that late treatment effects have on QoL. This was a prospective study involving 225...

  • A team approach to the complexities of Parkinson's. Nazarko, Linda // British Journal of Healthcare Assistants;Nov2013, Vol. 7 Issue 11, p533 

    As the population ages, the number of people with Parkinson's disease is set to rise. Providing quality care that meets the needs of the person with Parkinson's disease can present particular challenges to care givers. The disease means that self care ability and care needs may be difficult to...

  • Should Parkinson's patients take CoQ10?  // Life Extension;2004 Collectors Edition, Vol. 10, p18 

    The article reports that Parkinson's disease is the second most common degenerative brain disorder. The percentage of the population afflicted by Parkinson's is on the rise. Researchers question why some people develop Parkinson's while others escape its clutches. One of the answers under...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics